Research

New monoclonal antibody treatment for non-infectious uveitis

Uveitis is a disease that causes inflammation of the tissues inside the eye. More specifically, non-infectious uveitis (NIU) causes 20% of cases of blindness in developed countries. Until now, it has been treated with corticosteroids, but recently a biological therapy with Adalimumab (ADA), a human monoclonal antibody, has been obtaining promising short- and long-term results.